Case Study

CRO Oversight and Collaboration Success Story

Rethinking CRO Relationships

To avoid delays and cost overruns, one global biopharmaceutical company realized it had to do better when it came to CRO oversight.

Overview

The sponsor sought out a system that could provide real-time access to operational data in one place. The sponsor chose Operations Insights for CRO oversight and collaboration and Risk Based Monitoring for site performance.

Challenge

Poor data visibility, slow data reporting, and uncertainty about agreed-upon terms and quality plans were straining the sponsor’s relationship with its CROs. Information was siloed in nine different systems across three vendors and missed milestones regularly increased risk and added unnecessary costs.

Solution

Because the sponsor lacked the internal resources to create its own solution, executives looked at outside vendors for help. Saama was selected to integrate data into a common data model and use pre-built analytics to quickly identify issues.

Results

The new transparency enabled a more efficient use of resources and resulted in a more collaborative relationship between the sponsor and its CROs. Adverse events and protocol deviations are managed more quickly, performance has improved dramatically, and CRO change orders have markedly decreased.

Download Case Study
Primary Business
Biopharmaceuticals
Headquarters
Ireland
Employees
1,000+
Annual Revenue
$1.6B
Trial Portfolio
4 Studies
3 CROs
9 Data Systems
  • Download Case Study

  • You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

“We’re now in a much better position to collaborate with multiple CROs for better results, as we bring important new treatments to market.”

—VP of Clinical Operations

More Success Stories

Access Out-of-the-Box Features in 4 Weeks—Guaranteed.

Saama can put you on the fast track to clinical trial process innovation.